Dr Monica Robotin

Senior Lecturer
Public Health, School of Public Health

Telephone +61 2 9036 7137
Fax +61 2 9351 7420

Map

International links

Maldives

(Maldives National University, FAculty of Health Sciences ) Developed the curriculum for the country's first MPH program, using consensus-building methods in 2013. The first student intake commenced the course in January 2014. Will continue the collaboration wiht local academics (through an Endeavour Executive Award, funded by the Australian Government) to develop Public Health research priorities for the MNU.

Selected publications & creative works

Download citations: PDF RTF Endnote

Edited Books

  • Oliver, I., Robotin, M. (2012). Perspectives on Complementary and Alternative Medicines. London: Imperial College Press.
  • Robotin, M., Olver, I., Girgis, A. (2010). When Cancer Crosses Disciplines: A Physician's Handbook. London: Imperial College Press.
  • Matthews, G., Robotin, M. (2008). B positive-all you wanted to know about hepatitis B: a guide for primary care providers. Australia: ASHM - Australasian Society for HIV Medicine.

Book Chapters

  • Robotin, M. (2012). From Traditional Medicines to Drug Discovery. In Olver, I and Robotin, M (Eds.), Perspectives on Complementary and Alternative Medicines, (pp. 157-185). London: Imperial College Press.
  • Robotin, M. (2012). Randomised Controlled Trials in the Primary Treatment of Hepatocellular Carcinoma. In Liang Qiao, Yumin Li, Xiang Yan and Jacob George (Eds.), Molecular Aspects of Hepatocellular Carcinoma, (pp. 174-195). Sharjah: Bentham Science Publishers Ltd.
  • Sundquist, K., Robotin, M. (2010). What matters to patients and to carers. In Monica Robotin, Ian Olver, Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physicians Handbook, (pp. 317-341). London: Imperial College Press.
  • Robotin, M. (2008). Hepatitis b virus-related hepatocellular carcinoma. In Gail Matthews and Monica Robotin (Eds.), B positive-all you wanted to know about hepatitis B: a guide for primary care providers, (pp. 69-74). Australia: ASHM - Australasian Society for HIV Medicine.

Journals

  • Robotin, M., George, J. (2014). Community-based hepatitis B screening: what works. Hepatology International, 8(4), 478-492. [More Information]
  • Robotin, M., Kansil, M., Porwal, M., Penman, A., George, J. (2014). Community-based prevention of hepatitis-B-related liver cancer: Australian insights. Bulletin of the World Health Organization, 92(5), 374-379. [More Information]
  • Sitas, F., Gibberd, A., Kahn, C., Weber, M., Chiew, M., Supramaniam, R., Velentzis, L., Nickson, C., Smith, D., O'Connell, D., Yu, X., Canfell, K., Robotin, M., et al (2013). Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987-2007. Cancer Epidemiology, 37(6), 780-787. [More Information]
  • Robotin, M., Patton, Y., George, J. (2013). Getting it right: The impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providers. International Journal of General Medicine, 6(115), 122. [More Information]
  • Robotin, M., Patton, Y., Kansil, M., Penman, A., George, J. (2012). Cost of treating chronic hepatitis B: Comparison of current treatment guidelines. World Journal of Gastroenterology, 18(42), 6106-6113. [More Information]
  • Robotin, M., Holliday, C., Bensoussan, A. (2012). Defining research priorities in complementary medicine in oncology. Complementary Therapies in Medicine, 20(5), 345-352. [More Information]
  • Robotin, M. (2011). Botanical products in the 21st century: from whence to whither. Cancer Forum, 35(1), 6-9.
  • Robotin, M. (2011). Hepatitis B prevention and control: Lessons from the East and the West. World Journal of Hepatology, 3(2), 31-37. [More Information]
  • Robotin, M., Jones, S., Biankin, A., Waters, L., Iverson, D., Gooden, H., Barraclough, B., Penman, A. (2010). Defining research priorities for pancreatic cancer in Australia: results of a consensus development process. Cancer Causes and Control: an international journal of studies of cancer in human populations, 21(5), 729-736. [More Information]
  • Robotin, M. (2010). Enquiring about cancer patients' use of complementary and alternative medicines: Is our job done? Asia-Pacific Journal of Clinical Oncology, 6(4), 245-247. [More Information]
  • Holliday, C., Robotin, M. (2010). The Delphi process: a solution for reviewing novel grant applications. International Journal of General Medicine, 3, 225-230. [More Information]
  • Robotin, M., Kansil, M., George, J., Howard, K., Tipper, S., Levy, M., Phung, N., Penman, A. (2010). Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation. BMC Health Services Research, 10, 215-224. [More Information]
  • Robotin, M., Kansil, M., Howard, K., George, J., Tipper, S., Dore, G., Levy, M., Penman, A. (2009). Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. Journal of Hepatology, 50(5), 990-998. [More Information]
  • Saunders, C., Gooden, H., Robotin, M., Mumford, J. (2009). As the bell tolls: a foundation study on pancreatic cancer consumer's research priorities. BMC Research Notes, 2(179), 1-9. [More Information]
  • Alam, N., Robotin, M., Baker, D. (2009). Epidemiology of primary liver cancer. Cancer Forum, 33(2), 88-92.
  • George, J., Robotin, M. (2009). Overview: Hepatocellular carcinoma - the future starts now. Cancer Forum, 33(2), 83-87.
  • Saunders, C., Robotin, M., Crossing, S. (2008). By invitation only - the case for breast cancer screening reminders for women over 69 years. Australia and New Zealand Health Policy, 5(23), 23-1-23-6. [More Information]
  • Supramaniam, R., O'Connell, D., Robotin, M., Tracey, E., Sitas, F. (2008). Future cancer trends to be influenced by past and future migration. Australian and New Zealand Journal of Public Health, 32(1), 90-92. [More Information]
  • Robotin, M., George, J., Supramaniam, R., Sitas, F., Penman, A. (2008). Preventing primary liver cancer: how well are we faring towards a national hepatitis B strategy? Medical Journal of Australia, 188(6), 363-365. [More Information]
  • Robotin, M. (2008). Successful lung transplantation for adolescents at a hospital for adults. Medical Journal of Australia, 188(7), 430-1. [More Information]
  • Robotin, M., Penman, A. (2006). Integrating complementary therapies into mainstream cancer care: which way forward? Medical Journal of Australia, 185(7), 377-379. [More Information]
  • Robotin, M., Law, M., Milliken, S., Goldstein, D., Garsia, R., Dolan, G., Kaldor, J., Grulich, A. (2004). Clinical characteristics and determinants of survival following AIDS- related non-Hodgkin’s lymphoma in a population-based case series in Sydney, Australia. HIV Medicine, 5, 377-384.
  • Robotin, M., Copland, J., Tallis, G., Coleman, D., Giele, C., Carter, L., Spencer, J., Kaldor, J., Dore, G. (2004). Surveillance for newly acquired hepatitis C in Australia. Journal of Gastroenterology and Hepatology, 19(3), 283-288.

Research Reports

  • Robotin, M., Holliday, C. (2013). Research priorities for complementary medicine in Australia | Chapter 5 Cancer, (pp. 35 - 42). Campbelltown, Australia: National Institute of Complementary Medicine.
  • Feletto, E., Gibberd, A., Kahn, C., Armstrong, K., Canfell, K., Chiew, M., Grogan, P., Nickson, C., OConnell, D., Penman, A., Robotin, M., Smith, D., Yu, X., Sitas, F., et al (2013). The State of Cancer Control in Australia 1987–2007: Changes in cancer incidence and mortality, (pp. 1 - 166). Sydney, Australia: Cancer Council NSW.
  • Feletto, E., Gibberd, A., Kahn, C., Armstrong, K., Canfell, K., Chiew, M., Grogan, P., Nickson, C., OConnell, D., Penman, A., et al (2013). The State of Cancer Control in Australia: 1987–2007: Changes in cancer incidence and mortality, (pp. 13 - 165). NSW, Australia: Cancer Council NSW.

2014

  • Robotin, M., George, J. (2014). Community-based hepatitis B screening: what works. Hepatology International, 8(4), 478-492. [More Information]
  • Robotin, M., Kansil, M., Porwal, M., Penman, A., George, J. (2014). Community-based prevention of hepatitis-B-related liver cancer: Australian insights. Bulletin of the World Health Organization, 92(5), 374-379. [More Information]

2013

  • Sitas, F., Gibberd, A., Kahn, C., Weber, M., Chiew, M., Supramaniam, R., Velentzis, L., Nickson, C., Smith, D., O'Connell, D., Yu, X., Canfell, K., Robotin, M., et al (2013). Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987-2007. Cancer Epidemiology, 37(6), 780-787. [More Information]
  • Robotin, M., Patton, Y., George, J. (2013). Getting it right: The impact of a continuing medical education program on hepatitis B knowledge of Australian primary care providers. International Journal of General Medicine, 6(115), 122. [More Information]
  • Robotin, M., Holliday, C. (2013). Research priorities for complementary medicine in Australia | Chapter 5 Cancer, (pp. 35 - 42). Campbelltown, Australia: National Institute of Complementary Medicine.
  • Feletto, E., Gibberd, A., Kahn, C., Armstrong, K., Canfell, K., Chiew, M., Grogan, P., Nickson, C., OConnell, D., Penman, A., Robotin, M., Smith, D., Yu, X., Sitas, F., et al (2013). The State of Cancer Control in Australia 1987–2007: Changes in cancer incidence and mortality, (pp. 1 - 166). Sydney, Australia: Cancer Council NSW.
  • Feletto, E., Gibberd, A., Kahn, C., Armstrong, K., Canfell, K., Chiew, M., Grogan, P., Nickson, C., OConnell, D., Penman, A., et al (2013). The State of Cancer Control in Australia: 1987–2007: Changes in cancer incidence and mortality, (pp. 13 - 165). NSW, Australia: Cancer Council NSW.

2012

  • Robotin, M., Patton, Y., Kansil, M., Penman, A., George, J. (2012). Cost of treating chronic hepatitis B: Comparison of current treatment guidelines. World Journal of Gastroenterology, 18(42), 6106-6113. [More Information]
  • Robotin, M., Holliday, C., Bensoussan, A. (2012). Defining research priorities in complementary medicine in oncology. Complementary Therapies in Medicine, 20(5), 345-352. [More Information]
  • Robotin, M. (2012). From Traditional Medicines to Drug Discovery. In Olver, I and Robotin, M (Eds.), Perspectives on Complementary and Alternative Medicines, (pp. 157-185). London: Imperial College Press.
  • Oliver, I., Robotin, M. (2012). Perspectives on Complementary and Alternative Medicines. London: Imperial College Press.
  • Robotin, M. (2012). Randomised Controlled Trials in the Primary Treatment of Hepatocellular Carcinoma. In Liang Qiao, Yumin Li, Xiang Yan and Jacob George (Eds.), Molecular Aspects of Hepatocellular Carcinoma, (pp. 174-195). Sharjah: Bentham Science Publishers Ltd.

2011

  • Robotin, M. (2011). Botanical products in the 21st century: from whence to whither. Cancer Forum, 35(1), 6-9.
  • Robotin, M. (2011). Hepatitis B prevention and control: Lessons from the East and the West. World Journal of Hepatology, 3(2), 31-37. [More Information]

2010

  • Robotin, M., Jones, S., Biankin, A., Waters, L., Iverson, D., Gooden, H., Barraclough, B., Penman, A. (2010). Defining research priorities for pancreatic cancer in Australia: results of a consensus development process. Cancer Causes and Control: an international journal of studies of cancer in human populations, 21(5), 729-736. [More Information]
  • Robotin, M. (2010). Enquiring about cancer patients' use of complementary and alternative medicines: Is our job done? Asia-Pacific Journal of Clinical Oncology, 6(4), 245-247. [More Information]
  • Holliday, C., Robotin, M. (2010). The Delphi process: a solution for reviewing novel grant applications. International Journal of General Medicine, 3, 225-230. [More Information]
  • Robotin, M., Kansil, M., George, J., Howard, K., Tipper, S., Levy, M., Phung, N., Penman, A. (2010). Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation. BMC Health Services Research, 10, 215-224. [More Information]
  • Sundquist, K., Robotin, M. (2010). What matters to patients and to carers. In Monica Robotin, Ian Olver, Afaf Girgis (Eds.), When Cancer Crosses Disciplines: A Physicians Handbook, (pp. 317-341). London: Imperial College Press.
  • Robotin, M., Olver, I., Girgis, A. (2010). When Cancer Crosses Disciplines: A Physician's Handbook. London: Imperial College Press.

2009

  • Robotin, M., Kansil, M., Howard, K., George, J., Tipper, S., Dore, G., Levy, M., Penman, A. (2009). Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. Journal of Hepatology, 50(5), 990-998. [More Information]
  • Saunders, C., Gooden, H., Robotin, M., Mumford, J. (2009). As the bell tolls: a foundation study on pancreatic cancer consumer's research priorities. BMC Research Notes, 2(179), 1-9. [More Information]
  • Alam, N., Robotin, M., Baker, D. (2009). Epidemiology of primary liver cancer. Cancer Forum, 33(2), 88-92.
  • George, J., Robotin, M. (2009). Overview: Hepatocellular carcinoma - the future starts now. Cancer Forum, 33(2), 83-87.

2008

  • Matthews, G., Robotin, M. (2008). B positive-all you wanted to know about hepatitis B: a guide for primary care providers. Australia: ASHM - Australasian Society for HIV Medicine.
  • Saunders, C., Robotin, M., Crossing, S. (2008). By invitation only - the case for breast cancer screening reminders for women over 69 years. Australia and New Zealand Health Policy, 5(23), 23-1-23-6. [More Information]
  • Supramaniam, R., O'Connell, D., Robotin, M., Tracey, E., Sitas, F. (2008). Future cancer trends to be influenced by past and future migration. Australian and New Zealand Journal of Public Health, 32(1), 90-92. [More Information]
  • Robotin, M. (2008). Hepatitis b virus-related hepatocellular carcinoma. In Gail Matthews and Monica Robotin (Eds.), B positive-all you wanted to know about hepatitis B: a guide for primary care providers, (pp. 69-74). Australia: ASHM - Australasian Society for HIV Medicine.
  • Robotin, M., George, J., Supramaniam, R., Sitas, F., Penman, A. (2008). Preventing primary liver cancer: how well are we faring towards a national hepatitis B strategy? Medical Journal of Australia, 188(6), 363-365. [More Information]
  • Robotin, M. (2008). Successful lung transplantation for adolescents at a hospital for adults. Medical Journal of Australia, 188(7), 430-1. [More Information]

2006

  • Robotin, M., Penman, A. (2006). Integrating complementary therapies into mainstream cancer care: which way forward? Medical Journal of Australia, 185(7), 377-379. [More Information]

2004

  • Robotin, M., Law, M., Milliken, S., Goldstein, D., Garsia, R., Dolan, G., Kaldor, J., Grulich, A. (2004). Clinical characteristics and determinants of survival following AIDS- related non-Hodgkin’s lymphoma in a population-based case series in Sydney, Australia. HIV Medicine, 5, 377-384.
  • Robotin, M., Copland, J., Tallis, G., Coleman, D., Giele, C., Carter, L., Spencer, J., Kaldor, J., Dore, G. (2004). Surveillance for newly acquired hepatitis C in Australia. Journal of Gastroenterology and Hepatology, 19(3), 283-288.

To update your profile click here. For support on your academic profile contact .